Issue 3/2009
Content (12 Articles)
Editorial
Why the econometrician is in good spirits: a workshop through the looking glass
Carl Hampus Lyttkens
Original Paper
Exploring spatial patterns in general practice expenditure
Mickael Bech, Jørgen Lauridsen
Original Paper
Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
Douglas C. A. Taylor, Ankur Pandya, David Thompson, Paula Chu, Jennifer Graff, James Shepherd, Nanette Wenger, Heiner Greten, Rafael Carmena, Michael Drummond, Milton C. Weinstein
Original Paper
The economic costs of Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England
Elizabeth-Ann Schroeder, Stavros Petrou, Gail Balfour, Oya Edamma, Paul T. Heath
Original Paper
The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals
Ansgar Resch, Michael Wilke, Christian Fink
Original Paper
Hybrid risk adjustment for pharmaceutical benefits
Manuel García-Goñi, Pere Ibern, José María Inoriza
Original Paper
Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach
Bastian Haß, Juliane Lungershausen, Nadine Hertel, Barbara Poulsen Nautrup, Wioletta Kotowa, Hiltrud Liedgens
Original Paper
Material versus social deprivation and health: a case study of an urban area
Angela Testi, Enrico Ivaldi
Original Paper
Modelling health expenditure at the household level in Greece
Manos Matsaganis, Theodore Mitrakos, Panos Tsakloglou
Original Paper
Total costs of injury from accidents in the home and during education, sports and leisure activities: estimates for Norway with assessment of uncertainty
Knut Veisten, Åse Nossum, Juned Akhtar
Original Paper
The economics of cochlear implant management in France: a multicentre analysis
Laurent Molinier, Hélène Bocquet, Vanina Bongard, Bernard Fraysse